CVS Health To Close Acquisition Of Signify Health

3/27/23 6:52:36 AM ET

$CVS

$SGFY

Retail-Drug Stores and Proprietary Stores

Consumer Staples

Retail: Computer Software & Peripheral Equipment

Technology

Get the next $CVS alert in real time by email

The companies entered into a definitive agreement in September 2022 under which CVS Health announced it would acquire Signify Health for $30.50 per share in cash for a total transaction value of approximately $8 billion. Upon completion of the acquisition, Signify Health will continue to operate as a payor-agnostic business as part of CVS Health.

Get the next $CVS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CVS
$SGFY

Company	Date	Price Target	Rating	Analyst
CVS Health Corporation $CVS	11/18/2024	$60.00 → $66.00	Equal Weight → Overweight	Wells Fargo
CVS Health Corporation $CVS	10/10/2024	$63.00 → $82.00	Equal Weight → Overweight	Barclays
CVS Health Corporation $CVS	10/4/2024	$59.00 → $85.00	Hold → Buy	TD Cowen
CVS Health Corporation $CVS	5/30/2024	$61.00	Neutral	Robert W. Baird
CVS Health Corporation $CVS	5/7/2024	$99.00 → $59.00	Buy → Hold	TD Cowen
CVS Health Corporation $CVS	5/2/2024	$85.00 → $60.00	Buy → Neutral	UBS
CVS Health Corporation $CVS	5/1/2024		Overweight → Neutral	Cantor Fitzgerald
CVS Health Corporation $CVS	5/1/2024	$87.00 → $60.00	Outperform → Market Perform	Leerink Partners

More analyst ratings

$CVS
$SGFY
Market Insights

Live Market Insights

A Closer Look at CVS Health's Options Market Dynamics
Financial giants have made a conspicuous bullish move on CVS Health. Our analysis of options history for CVS Health (NYSE:CVS) revealed 10 unusual trades. Delving into the details, we found 50% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $374,736, and 7 were calls, valued at $388,184. Expected Price Movements Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $53.0 to $77.5 for CVS Health over the last 3 months. Analyzing Volume & Open Interest Assessing the volume and open interest is a strategic step in options trading. These metr
7/24/24 3:46:17 PM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
Deep Dive Into CVS Health Stock: Analyst Perspectives (15 Ratings)
Across the recent three months, 15 analysts have shared their insights on CVS Health (NYSE:CVS), expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 1 9 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 2 0 0 3M Ago 5 0 6 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $66.13, along with a high estimate of $86.00 and a low estimate of $58.00. Observing
7/23/24 1:01:45 PM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
Cantor Fitzgerald Reiterates Neutral on CVS Health, Maintains $58 Price Target
Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $58 price target.
7/23/24 12:03:09 PM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples

$CVS
$SGFY
Press Releases

Fastest customizable press release news feed in the world

CVS Health names Dr. Sreekanth Chaguturu President, Health Care Delivery
WOONSOCKET, R.I., Nov. 19, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Dr. Sreekanth Chaguturu will be President, Health Care Delivery, in addition to his current role as Executive Vice President and Chief Medical Officer of CVS Health. Dr. Chaguturu replaces Mike Pykosz, who has decided to leave the company. "Sree and I worked closely together when he started at CVS Health, serving as chief medical officer of CVS Caremark. In that role, and as the leader of Medical Affairs at our company, Sree has served as a trusted advisor to our clients, their members
11/19/24 10:30:00 AM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
CVS Health Announces Board Appointments
CVS Health Board of Directors appoints four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman Appointments follow productive engagement with Glenview Capital Management WOONSOCKET, R.I., Nov. 18, 2024 /PRNewswire/ -- The Board of Directors of CVS Health (NYSE:CVS) today announced the appointment of four new board members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman, following productive discussions with Glenview Capital Management. "In our discussions with the leadership at Glenview, we agreed that we can deliver greater value from our
11/18/24 6:30:00 AM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
CVS Health to present at the Wolfe 2024 Healthcare Conference
WOONSOCKET, R.I., Nov. 11, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the Wolfe 2024 Healthcare Conference on November 19, 2024, at approximately 10:20 am ET. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels a
11/11/24 2:00:00 PM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples

$CVS
$SGFY
Financials

Live finance-specific insights

CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2024 RESULTS
Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior yearThird quarter GAAP diluted EPS of $0.07 and Adjusted EPS of $1.09Third quarter GAAP diluted EPS and Adjusted EPS include charges to record premium deficiency reserves of approximately $1.1 billion ($0.63 per share) in the Health Care Benefits segmentGenerated year-to-date cash flow from operations of $7.2 billionCEO Commentary "Our integrated model accelerates our ability to uniquely do what is most important to today's health care consumers: deliver lower cost of care, a simpler experience and better outcomes. Our third quarter results reflect strong performance in the Health Serv
11/6/24 6:30:00 AM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
CVS Health to hold third quarter 2024 earnings conference call
WOONSOCKET, R.I., Oct. 7, 2024 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, November 6th, 2024, at 8:00 a.m. ET to discuss third quarter 2024 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — includi
10/7/24 9:00:00 AM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
CVS Health announces quarterly dividend
WOONSOCKET, R.I., Sept. 19, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on November 1, 2024, to holders of record on October 21, 2024. About CVS HealthCVS Health® is the leading health solutions company, broadening access to care for millions of people nationwide. We improve the health of communities across America through our local presence, digital channels and with over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. We support i
9/19/24 11:02:00 AM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples

$CVS
$SGFY
Leadership Updates

Live Leadership Updates

CVS Health Announces Board Appointments
CVS Health Board of Directors appoints four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman Appointments follow productive engagement with Glenview Capital Management WOONSOCKET, R.I., Nov. 18, 2024 /PRNewswire/ -- The Board of Directors of CVS Health (NYSE:CVS) today announced the appointment of four new board members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman, following productive discussions with Glenview Capital Management. "In our discussions with the leadership at Glenview, we agreed that we can deliver greater value from our
11/18/24 6:30:00 AM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
CVS Health Announces Leadership Appointments
Prem Shah named Group President, CVS Health; Steve Nelson named President, Aetna WOONSOCKET, R.I., Nov. 6, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced Prem Shah will be Group President, and will continue to report to David Joyner, President and Chief Executive Officer. In addition, the company announced the appointment of Steve Nelson as President, Aetna, and he will also report to Joyner. Both appointments are effective today. As Group President, Shah will be responsible for the operational performance and integrated value creation across CVS Caremark, CVS Pha
11/6/24 6:30:00 AM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
CVS Health Appoints David Joyner President and Chief Executive Officer
Roger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10 WOONSOCKET, R.I., Oct. 18, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced that David Joyner was appointed President and Chief Executive Officer, effective October 17, replacing Karen Lynch, who stepped down from her position in agreement with the company's Board of Directors. Joyner also joined the Board of Directors. In addition, current Chairman of the Board, Roger Farah, will now be Executive Chairman.
10/18/24 6:30:00 AM ET
$CVS
Retail-Drug Stores and Proprietary Stores
Consumer Staples

CVS Health To Close Acquisition Of Signify Health

Chat with this insight

Recent Analyst Ratings for $CVS$SGFY

$CVS$SGFY Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by CVS Health Corporation

SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

$CVS$SGFY SEC Filings

CVS Health Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure

SEC Form 13F-HR filed by CVS Health Corporation

CVS Health Corporation filed SEC Form 8-K: Regulation FD Disclosure

$CVS$SGFY Market Insights

Live Market Insights

A Closer Look at CVS Health's Options Market Dynamics

Deep Dive Into CVS Health Stock: Analyst Perspectives (15 Ratings)

Cantor Fitzgerald Reiterates Neutral on CVS Health, Maintains $58 Price Target

$CVS$SGFY Press Releases

Fastest customizable press release news feed in the world

CVS Health names Dr. Sreekanth Chaguturu President, Health Care Delivery

CVS Health Announces Board Appointments

CVS Health to present at the Wolfe 2024 Healthcare Conference

$CVS$SGFY Financials

Live finance-specific insights

CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2024 RESULTS

CVS Health to hold third quarter 2024 earnings conference call

CVS Health announces quarterly dividend

$CVS$SGFY Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 3 filed by new insider Nelson Steven H

SEC Form 3 filed by new insider Capozzi Heidi B

EVP, Chief Technology Officer Mandadi Tilak covered exercise/tax liability with 13,097 shares, decreasing direct ownership by 24% to 40,414 units (SEC Form 4)

$CVS$SGFY Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

CVS Health upgraded by Wells Fargo with a new price target

CVS Health upgraded by Barclays with a new price target

CVS Health upgraded by TD Cowen with a new price target

$CVS$SGFY Leadership Updates

Live Leadership Updates

CVS Health Announces Board Appointments

CVS Health Announces Leadership Appointments

CVS Health Appoints David Joyner President and Chief Executive Officer

$CVS$SGFY Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Ludwig Edward J bought $53,879 worth of shares (1,000 units at $53.88), increasing direct ownership by 5% to 21,630 units (SEC Form 4)

Mahoney Michael F bought $500,294 worth of shares (9,181 units at $54.49), increasing direct ownership by 5,246% to 9,356 units (SEC Form 4)

Ludwig Edward J bought $140,930 worth of shares (2,000 units at $70.47), increasing direct ownership by 11% to 20,630 units (SEC Form 4)

Recent Analyst Ratings for
$CVS
$SGFY

$CVS
$SGFY
Large Ownership Changes

$CVS
$SGFY
SEC Filings

$CVS
$SGFY
Market Insights

$CVS
$SGFY
Press Releases

$CVS
$SGFY
Financials

$CVS
$SGFY
Insider Trading

$CVS
$SGFY
Analyst Ratings

$CVS
$SGFY
Leadership Updates

$CVS
$SGFY
Insider Purchases